The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.
The test confirms the scientific validity of the biomarkers used in the lab, led by researcher Carleara Weiss, and increases ...
IFLScience on MSN
This Newly Discovered Blood Type Is So Rare, Only 3 People In The World Are Known To Have It
Imagine having a blood type so rare that only two other people in the entire world could match it. That’s the reality for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback